Targeting PI3K/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT. (Q38989855)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Targeting PI3K/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT.
scientific article

    Statements

    Targeting PI3K/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT. (English)
    30 May 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit